D. Henrion et al., The deletion genotype of the angiotensin I-converting enzyme is associatedwith an increased vascular reactivity in vivo and in vitro, J AM COL C, 34(3), 1999, pp. 830-836
Citations number
35
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
OBJECTIVES To define a link between the deletion genotype (DD) and vascular
reactivity, we studied in vivo and in vitro phenylephrine (PE)-induced ton
e and the effect of angiotensin II (AII) at physiological (subthreshold) co
ncentrations on PE-induced tone.
BACKGROUND The deletion allele (D) of the angiotensin I-converting enzyme (
ACE) has been associated with a higher circulating and cellular ACE activit
y and possibly with, some cardiovascular diseases.
METHODS During cardiac surgery PE-induced contraction was studied in patien
ts with excessive hypotension. In parallel, excess material of internal mam
mary artery, isolated from patients operated for bypass surgery, was mounte
d in an organ chamber, in vitro, for isometric vascular wall force measurem
ent.
RESULTS In patients under extracorporeal circulation, PE (25 to 150 mu g) i
nduced higher contractions in patients with the DD genotype (e.g., with PE
75 mu g: 20.3 +/- 2.9 vs. 11.5 +/- 2.5 mm Hg/ml per min, DD vs. II/ID, n =
15 vs. 30, p < 0.03). In the mammary artery, in vitro, contractions to PE (
0.1 to 100 mu mol/liter) or AII (1 or 100 nmol/liter) were not affected by
the genotype. Angiotensin II (10 pmol/liter) significantly potentiated PE (
1 mu mol/liter)induced contraction in both groups. Potentiation of PE-induc
ed tone by AII was significantly higher in the DD than in the II/ID group.
CONCLUSIONS The DD genotype was associated with an increased reactivity to
PE in vivo and potentiating effect of exogenous AII in vitro. The higher re
sponse to PE in vivo might reflect a higher potentiation by endogenous AII.
These data should be considered to understand possible link(s) between car
diovascular disorders and the ACE gene polymorphism. (J Am Coil Cardiol 199
9;34:830-6) (C) 1999 by the American College of Cardiology.